The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Melanoma Intrinsic-catenin Signaling on Immune Exclusion and Resistance to Immunotherapies

Stefani Spranger, PhD
Published Online: 7:19 PM, Tue June 30, 2015

Stefani Spranger, PhD, post-doctoral fellow, Department of Pathology, The University of Chicago Medicine, discusses the significance of melanoma intrinsic β-catenin signaling on immune exclusion and resistance to immunotherapies.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.